NanoVation Therapeutics™

Biotechnology Research • 2665 East Mall, Vancouver, Canada • 21-50 Employees

Company overview

Headquarters	2665 East Mall, Vancouver, British Columbia V6T 1Z4, CA
Website	nanovationtx.com
NAICS	541714
Keywords	Lipid Nanoparticles
Founded	2020
Employees	21-50
Socials

Key Contacts at NanoVation Therapeutics™

Dominik Witzigmann

Managing Director - Nanovation Therapeutics Europe

Jayesh Kulkarni

Chief Scientific Officer And Co-Founder

Eric Jan

Co-Founder And Advisor

NanoVation Therapeutics™ Email Formats

NanoVation Therapeutics™ uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@nanovationtx.com), used 75.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@nanovationtx.com	75.5%
{first initial}.{last name}	j.doe@nanovationtx.com	24.5%

About NanoVation Therapeutics™

NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery). NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies. NanoVation partners with leading pharmaceutical and biotech companies develop genetic medicines for previously untreatable diseases. NVTx is delivering tomorrow's genetic medicines, today. For more information, please visit nanovationtx.com.

NanoVation Therapeutics™ revenue & valuation

Annual revenue	$3,678,865
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,800,000
Total funding	$300,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Senior

Employees by Department

NanoVation Therapeutics™ has 22 employees across 12 departments.

Departments

Number of employees

Funding Data

Explore NanoVation Therapeutics™'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-10-29	9	$300,000
2024-12-19	3	N/A

Funding Insights

$300,000

Total funding amount

Number of funding rounds

NanoVation Therapeutics™ Tech Stack

Discover the technologies and tools that power NanoVation Therapeutics™'s digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Cloudflare Bot Management

Security

jQuery Mobile

Mobile frameworks

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

Frequently asked questions

NanoVation Therapeutics™ is located in 2665 East Mall, Vancouver, CA.

NanoVation Therapeutics™ was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

NanoVation Therapeutics™ has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

NanoVation Therapeutics™ has raised a total of $300,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at NanoVation Therapeutics™

Dominik Witzigmann

Managing Director - Nanovation Therapeutics Europe

Jayesh Kulkarni

Chief Scientific Officer And Co-Founder

Eric Jan

Co-Founder And Advisor

4.8

40,000 users